Atlas Trials

Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment

Clinical trial NCT00121992 · COMPLETED

Trial details

NCT number
NCT00121992
Sponsor
Spanish Breast Cancer Research Group
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Neoplasms
Start date
1999-07-01
Primary completion
2010-12-02
Enrollment
1060

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.